Skip to main content
Premium Trial:

Request an Annual Quote

Dana-Farber Inks Research, Supply Deal for MorphoSys' Slonomics Tech

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MorphoSys' AbD Serotec unit today announced a research and supply agreement to provide the Dana-Farber Cancer Institute with its Slonomics technology.

Under the terms of the deal, research tools using the technology will be placed in the laboratory of Wayne Marasco at Dana-Farber. The Department of Cancer Immunology and AIDS at the institute is conducting research to develop transient immunity against life-threatening viral infections as part of a project funded by the Defense Advanced Research Projects Agency of the US Department of Defense.

MorphoSys acquired the Slonomics technology from Sloning Biotechnology in October for $26.5 million. Slonomics is a synthetic biology technology that enables the construction of protein libraries.

AbD Serotec has preferred access to the rights to commercialize products resulting from the agreement.

Other financial terms were not disclosed.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.